BiotechFQ

Présence dans les classements

Les meilleurs jours où les posts de ce compte sont entrés dans le top quotidien de Debya.

Ce compte n’est encore apparu dans aucun classement quotidien.

Posts aimés récemment

J’aime publics du réseau Bluesky.

• BioPharmCatalyst@biopharmcatalyst.bsky.social12/03/2025 18:33

  $ARVN Phase 3 VERITAC-2 trial showed that Vepdegestrant monotherapy significantly improves progression-free survival in ER+/HER2 breast cancer patients with ESR1 mutations, but not in the overall patient population. See More Biotech Updates👇 www.biopharmcatalyst.com/news/2025/2s...

  Voir le post
• Rich Law@drrichjlaw.bsky.social12/03/2025 18:33

  Roche signs biggest-ever obesity drug deal with Danish Zealand Pharma; $5.3bn licensing agreement for next-generation treatment. www.ft.com/content/80c5...

  Voir le post
• Rich Law@drrichjlaw.bsky.social12/03/2025 10:50

  Zealand Pharma ( $ZEAL.CO) partners with Roche on its amylin analog in a deal worth up to $5.3B, plus 50% upside on profits, with $1.65Bn upfront! 👏 endpts.com/zealand-part...

  Voir le post
• BioPharmCatalyst@biopharmcatalyst.bsky.social11/03/2025 17:52

  $TSVT announced a merger agreement with $BMY to be acquired for $5.00 per share in an all-cash deal valued at $286 million, representing an 88% premium to its March 7, 2025 closing price. See More Pre-market Movers 👇 www.biopharmcatalyst.com/news/2025/2s... $ARVN $CUTR $SNOA $TNON $BVS $MYO $HCSC

  Voir le post
• BioPharmCatalyst@biopharmcatalyst.bsky.social08/03/2025 14:16

  $BTAI announced that it has achieved 33% enrollment in its 200-patient SERENITY At-Home trial, a pivotal Phase 3 study assessing the safety of BXCL501. See More Biotech Updates👇 www.biopharmcatalyst.com/news/2025/bi...

  Voir le post

Connectez-vous pour en voir plus

Comptes bloqués

Sur Bluesky, les blocages sont publics.

Ce compte ne bloque personne.